EMEA-002033-PIP01-16-M03
Key facts
Invented name |
Voxzogo
|
Active substance |
Vosoritide
|
Therapeutic area |
Other
|
Decision number |
P/0453/2022
|
PIP number |
EMEA-002033-PIP01-16-M03
|
Pharmaceutical form(s) |
Powder for solution for injection
|
Condition(s) / indication(s) |
Treatment of achondroplasia
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
BioMarin International Limited
Tel. +44 (0)20 7420 0800 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|